Developers of SMA Therapy Spinraza to Be Honored with $3M Prize at ‘Oscars of Science’
Pharmacologist C. Frank Bennett, PhD, and biochemist Adrian R. Krainer, PhD, have been awarded a prestigious 2019 Breakthrough Prize in Life Sciences for their role in the development of Spinraza (nusinersen), a therapy for spinal muscular atrophy (SMA). Bennett, of Ionis Pharmaceuticals, and Krainer, of Cold Spring Harbor…